Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors as of Sept. 30, 2021

Portfolio Holdings for Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors holds 33 positions in its portfolio as reported in the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 19.0 $307M 4.8M 63.44
Dynavax Technologies Corp Com New (DVAX) 10.0 $162M 8.4M 19.21
Rapid Micro Biosystems Class A Com (RPID) 9.7 $156M 8.4M 18.47
Atea Pharmaceuticals (AVIR) 8.0 $130M 3.7M 35.06
Adagio Therapeutics (IVVD) 6.5 $105M 2.5M 42.24
Arcutis Biotherapeutics (ARQT) 5.9 $95M 4.0M 23.89
Nuvalent Inc-a (NUVL) 4.8 $77M 3.4M 22.55
C4 Therapeutics Com Stk (CCCC) 4.6 $73M 1.6M 44.68
Dicerna Pharmaceuticals 3.9 $62M 3.1M 20.16
Annexon (ANNX) 3.7 $60M 3.2M 18.61
Pharvaris N V (PHVS) 3.5 $56M 3.2M 17.73
Nurix Therapeutics (NRIX) 2.4 $39M 1.3M 29.96
Crinetics Pharmaceuticals In (CRNX) 2.2 $35M 1.7M 21.05
Mersana Therapeutics 2.2 $35M 3.7M 9.43
Syros Pharmaceuticals 1.6 $26M 5.8M 4.47
Tango Therapeutics (TNGX) 1.5 $25M 1.9M 12.93
Aeglea Biotherapeutics 1.4 $23M 2.8M 7.95
Aptinyx 1.3 $21M 8.9M 2.34
Solid Biosciences 1.2 $19M 7.9M 2.39
Marinus Pharmaceuticals Com New 1.0 $16M 1.4M 11.38
Savara (SVRA) 1.0 $16M 12M 1.38
Nautilus Biotechnology (NAUT) 0.8 $12M 2.0M 6.14
X4 Pharmaceuticals 0.7 $11M 2.1M 5.29
Research Alliance Corp Ii Com Cl A 0.6 $9.9M 1.0M 9.85
Bluebird Bio 0.4 $7.2M 538k 13.45
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.4 $7.0M 700k 10.05
Arya Sciences Acquisitn Corp Class A Ord Shs 0.3 $4.9M 500k 9.88
Panacea Acquisition Corp Ii Cl A Shs 0.3 $4.9M 500k 9.77
Bcls Acquisition Corp Com Cl A 0.3 $4.9M 488k 9.96
Omega Alpha Spac Cl A 0.2 $3.9M 400k 9.73
Frazier Lifesciences Acqu Unit 12/09/2025 0.2 $3.0M 300k 10.03
Jiya Acquisition Corp Com Cl A 0.2 $2.9M 300k 9.75
Helix Acquisition Corp Com Cl A 0.2 $2.5M 250k 9.95